These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9866424)

  • 61. [Cardiac tamponade as an initial manifestation of acute myeloblastic leukemia].
    Kawasaki M; Yamano Y; Kikuchi Y; Sata T; Harada M; Niho Y
    Rinsho Ketsueki; 1990 Feb; 31(2):224-8. PubMed ID: 2329685
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Preliminary evaluation of adverse effects after administration of arabinoside cytosine (Ara-C) in high doses to children with acute myelogenous leukemia].
    Wysocki M; Kurylak A; Pilecki O; Balcar-Boroń A
    Acta Haematol Pol; 1994; 25(1):37-42. PubMed ID: 8209612
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pulmonary complications of cytosine-arabinoside therapy: radiographic findings.
    Tham RT; Peters WG; de Bruïne FT; Willemze R
    AJR Am J Roentgenol; 1987 Jul; 149(1):23-7. PubMed ID: 3495987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases].
    Castaigne S; Tilly H; Sigaux F; Solal Celigny P; Bordessoule D; Brière J; Colombat P; Donadio D; Drony S; Guy H
    Nouv Rev Fr Hematol (1978); 1985; 27(6):377-82. PubMed ID: 3867852
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Cytosine arabinoside in low doses in the treatment of myelodysplastic syndrome. Czechoslovak MDS Cooperative Group].
    Neuwirtová R
    Vnitr Lek; 1992 Jan; 38(1):27-32. PubMed ID: 1561770
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Myelodysplasia predominantly involving in megakaryocytic lineage successfully treated with low-dose Ara-C].
    Tsushita K; Hotta T; Inoue C; Ichikawa A; Murate T; Saito H
    Rinsho Ketsueki; 1991 Aug; 32(8):897-902. PubMed ID: 1942532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.
    Yang X; Liu W; Lyons A; Song Z; Zhai S; Hu K
    Eur J Clin Pharmacol; 2018 Feb; 74(2):181-182. PubMed ID: 29080058
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A therapeutic trial with low-dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a study of 15 cases].
    Maruta A; Miyashita H; Kodama F; Harano H; Kanamori H; Takahashi K; Noguchi T; Matsuzaki M; Ogawa K; Motomura S
    Rinsho Ketsueki; 1988 Jan; 29(1):8-13. PubMed ID: 3385938
    [No Abstract]   [Full Text] [Related]  

  • 69. [Low dose Ara-C for remission induction in aged patients with atypical nonlymphocytic leukemia and refractory anemia with excess blasts].
    Sawada H; Yamagishi M; Mochizuki T; Ishikura H; Izumi Y; Park YH; Wano M; Usui T; Uchino H
    Rinsho Ketsueki; 1983 Nov; 24(11):1464-72. PubMed ID: 6584648
    [No Abstract]   [Full Text] [Related]  

  • 70. Pericarditis induced by high-dose cytarabine therapy.
    Vaickus L; Letendre L
    Arch Intern Med; 1984 Sep; 144(9):1868-9. PubMed ID: 6477012
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of low-dose cytarabine therapy in myelodysplastic syndromes.
    el Mangoush M; Singh MK; Kumar S; Korajkio M; Gamati A
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():100. PubMed ID: 2627594
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
    Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Small-dose cytarabine (Ara-C) in the treatment of myelodysplastic syndrome].
    Dan K; Ogata K; Gomi S; Ohki I; Kuwabara T; Horikoshi H; Nomura T
    Rinsho Ketsueki; 1984 Oct; 25(10):1600-5. PubMed ID: 6596446
    [No Abstract]   [Full Text] [Related]  

  • 74. [Use of small, moderate and large doses of cytarabine (ARA-C) in the treatment of leukemia and other diseases of the hematopoietic system].
    Robak T
    Acta Haematol Pol; 1986; 17(1-2):63-70. PubMed ID: 3535345
    [No Abstract]   [Full Text] [Related]  

  • 75. Ara-C syndrome during low-dose continuous infusion therapy.
    Powell BL; Zekan PJ; Muss HB; Richards F; Lyerly ES; Capizzi RL
    Med Pediatr Oncol; 1986; 14(6):310-2. PubMed ID: 3784982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).
    Hellström E; Robèrt KH; Samuelsson J; Lindemalm C; Grimfors G; Kimby E; Oberg G; Winqvist I; Billström R; Carneskog J
    Eur J Haematol; 1990 Nov; 45(5):255-61. PubMed ID: 2261951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-dose Ara-C as maintenance treatment in AML.
    Catalano L; Fontana R; Selleri C; De Rosa G; Rotoli B
    Haematologica; 1989; 74(4):412-3. PubMed ID: 2507418
    [No Abstract]   [Full Text] [Related]  

  • 78. [Pericarditis as the presenting manifestation of acute monoblastic leukemia-Report of a case and review of the literature (author's transl)].
    Aymard JP; Voiriot P; Witz F; Colomb JN; Lederlin P; Thibaut G; Guerci O; Herbeuval R
    Ann Med Interne (Paris); 1980; 131(5):302-4. PubMed ID: 6934704
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pericarditis in the course of acute leukemia.
    Nowicka J; Haus O; Dzik T; Kaiser A; Kowalewska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(2):220-33. PubMed ID: 2440778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
    Tsutsumi H; Kumakawa T; Hirai M; Kikukawa M; Arie Y; Mori M; Kodo H; Nakamura N; Murai Y; Mizutani R
    Nihon Ronen Igakkai Zasshi; 1995 Mar; 32(3):190-4. PubMed ID: 7596061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.